The Michael J. Fox Foundation

Michael J Fox Foundation for Parkinson’s Research – Alpha-synuclein seed amplification assay programme

Bandi, Non EU, The Michael J. Fox Foundation /

The Michael J Fox Foundation for Parkinson’s Research invites applications for its alpha-synuclein seed amplification assay programme. This supports research that will facilitate integration of alpha-synuclein seed amplification assays into clinical studies for the purposes of predicting prognosis, tracking disease progression and monitoring therapeutic response. Applicants are encouraged to submit proposals that address one or […]

Michael J Fox Foundation for Parkinson’s Research – Alpha-synuclein seed amplification assay programme Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Bando Target Advancement Program

Bandi, Non EU, The Michael J. Fox Foundation /

The Target Advancement Program is open to industry and academic investigators proposing to build conclusive evidence to rationalize biological targets and pathways for Parkinson’s disease (PD) therapeutic development. Part of our Edmond J. Safra Core Programs for PD Research, this program will support projects focused on validating targets and defining pathways implicated in PD pathological processes

The Michael J.Fox Foundation for Parkinson’s Research – Bando Target Advancement Program Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Bando Parkinson’s Pathway Biomarkers

Bandi, Non EU, The Michael J. Fox Foundation /

Currently, many efforts are focusing on understanding the role of various cellular processes/pathways in PD and uncovering novel targets within these pathways for therapeutic development. As such, sensitive biomarker readouts for these pathways will be critical for bridging the gap from basic to translational research and clinical trials. The Parkinson’s Pathway Biomarkers program is open

The Michael J.Fox Foundation for Parkinson’s Research – Bando Parkinson’s Pathway Biomarkers Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Therapeutic Pipeline Program

Bandi, Non EU, The Michael J. Fox Foundation /

The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from other disease indications. Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program advances Parkinson’s disease therapeutic and intervention development along the pre-clinical and clinical path. Applications should focus on studies

The Michael J.Fox Foundation for Parkinson’s Research – Therapeutic Pipeline Program Leggi tutto »

Torna in alto